Cargando…

No development of ciprofloxacin resistance in the Haemophilus species associated with pneumonia over a 10-year study

BACKGROUND: The widespread overuse of antibiotics promotes the development of antibiotic resistance in bacteria, which can cause severe illness and constitutes a major public health concern. Haemophilus species are a common cause of community- and nosocomial-acquired pneumonia. The antibiotic resist...

Descripción completa

Detalles Bibliográficos
Autores principales: Yayan, Josef, Ghebremedhin, Beniam, Rasche, Kurt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4644324/
https://www.ncbi.nlm.nih.gov/pubmed/26567094
http://dx.doi.org/10.1186/s12879-015-1267-3
_version_ 1782400657318215680
author Yayan, Josef
Ghebremedhin, Beniam
Rasche, Kurt
author_facet Yayan, Josef
Ghebremedhin, Beniam
Rasche, Kurt
author_sort Yayan, Josef
collection PubMed
description BACKGROUND: The widespread overuse of antibiotics promotes the development of antibiotic resistance in bacteria, which can cause severe illness and constitutes a major public health concern. Haemophilus species are a common cause of community- and nosocomial-acquired pneumonia. The antibiotic resistance of these Gram-negative bacteria can be prevented through the reduction of unnecessary antibiotic prescriptions, the correct use of antibiotics, and good hygiene and infection control. This article examines, retrospectively, antibiotic resistance in patients with community- and nosocomial-acquired pneumonia caused by Haemophilus species. METHODS: The demographic, clinical, and laboratory data of all patients with community- and nosocomial-acquired pneumonia caused by Haemophilus species were collected from the hospital charts at the HELIOS Clinic, Witten/Herdecke University, Wuppertal, Germany, within a study period from 2004 to 2014. Antimicrobial susceptibility testing was performed for the different antibiotics that have been consistently used in the treatment of patients with pneumonia caused by Haemophilus species. RESULTS: During the study period of January 1, 2004, to August 12, 2014, 82 patients were identified with community- and nosocomial-acquired pneumonia affected by Haemophilus species. These patients had a mean age of 63.8 ± 15.5 (60 [73.2 %, 95 % CI 63.6 %–82.8 %] males and 22 [26.8 %, 95 % CI 17.2 %–36.4 %] females). Haemophilus species had a high resistance rate to erythromycin (38.3 %), ampicillin (24.4 %), piperacillin (20.8 %), cefuroxime (8.5 %), ampicillin-sulbactam (7.3 %), piperacillin-sulbactam (4.3 %), piperacillin-tazobactam (2.5 %), cefotaxime (2.5 %), and levofloxacin (1.6 %). In contrast, they were not resistant to ciprofloxacin in patients with pneumonia (P = 0.016). CONCLUSION: Haemophilus species were resistant to many of the typically used antibiotics. Resistance toward ciprofloxacin was not detected in patients with pneumonia caused by Haemophilus species.
format Online
Article
Text
id pubmed-4644324
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46443242015-11-15 No development of ciprofloxacin resistance in the Haemophilus species associated with pneumonia over a 10-year study Yayan, Josef Ghebremedhin, Beniam Rasche, Kurt BMC Infect Dis Research Article BACKGROUND: The widespread overuse of antibiotics promotes the development of antibiotic resistance in bacteria, which can cause severe illness and constitutes a major public health concern. Haemophilus species are a common cause of community- and nosocomial-acquired pneumonia. The antibiotic resistance of these Gram-negative bacteria can be prevented through the reduction of unnecessary antibiotic prescriptions, the correct use of antibiotics, and good hygiene and infection control. This article examines, retrospectively, antibiotic resistance in patients with community- and nosocomial-acquired pneumonia caused by Haemophilus species. METHODS: The demographic, clinical, and laboratory data of all patients with community- and nosocomial-acquired pneumonia caused by Haemophilus species were collected from the hospital charts at the HELIOS Clinic, Witten/Herdecke University, Wuppertal, Germany, within a study period from 2004 to 2014. Antimicrobial susceptibility testing was performed for the different antibiotics that have been consistently used in the treatment of patients with pneumonia caused by Haemophilus species. RESULTS: During the study period of January 1, 2004, to August 12, 2014, 82 patients were identified with community- and nosocomial-acquired pneumonia affected by Haemophilus species. These patients had a mean age of 63.8 ± 15.5 (60 [73.2 %, 95 % CI 63.6 %–82.8 %] males and 22 [26.8 %, 95 % CI 17.2 %–36.4 %] females). Haemophilus species had a high resistance rate to erythromycin (38.3 %), ampicillin (24.4 %), piperacillin (20.8 %), cefuroxime (8.5 %), ampicillin-sulbactam (7.3 %), piperacillin-sulbactam (4.3 %), piperacillin-tazobactam (2.5 %), cefotaxime (2.5 %), and levofloxacin (1.6 %). In contrast, they were not resistant to ciprofloxacin in patients with pneumonia (P = 0.016). CONCLUSION: Haemophilus species were resistant to many of the typically used antibiotics. Resistance toward ciprofloxacin was not detected in patients with pneumonia caused by Haemophilus species. BioMed Central 2015-11-13 /pmc/articles/PMC4644324/ /pubmed/26567094 http://dx.doi.org/10.1186/s12879-015-1267-3 Text en © Yayan et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Yayan, Josef
Ghebremedhin, Beniam
Rasche, Kurt
No development of ciprofloxacin resistance in the Haemophilus species associated with pneumonia over a 10-year study
title No development of ciprofloxacin resistance in the Haemophilus species associated with pneumonia over a 10-year study
title_full No development of ciprofloxacin resistance in the Haemophilus species associated with pneumonia over a 10-year study
title_fullStr No development of ciprofloxacin resistance in the Haemophilus species associated with pneumonia over a 10-year study
title_full_unstemmed No development of ciprofloxacin resistance in the Haemophilus species associated with pneumonia over a 10-year study
title_short No development of ciprofloxacin resistance in the Haemophilus species associated with pneumonia over a 10-year study
title_sort no development of ciprofloxacin resistance in the haemophilus species associated with pneumonia over a 10-year study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4644324/
https://www.ncbi.nlm.nih.gov/pubmed/26567094
http://dx.doi.org/10.1186/s12879-015-1267-3
work_keys_str_mv AT yayanjosef nodevelopmentofciprofloxacinresistanceinthehaemophilusspeciesassociatedwithpneumoniaovera10yearstudy
AT ghebremedhinbeniam nodevelopmentofciprofloxacinresistanceinthehaemophilusspeciesassociatedwithpneumoniaovera10yearstudy
AT raschekurt nodevelopmentofciprofloxacinresistanceinthehaemophilusspeciesassociatedwithpneumoniaovera10yearstudy